HOSU-3 is a dihydroorotate dehydrogenase (DHODH) inhibitor currently being tested at The Ohio State University for the treatment of Non-Hodgkin's lymphoma (IMAGE)

Ohio State University Wexner Medical Center

HOSU-3 is a dihydroorotate dehydrogenase (DHODH) inhibitor currently being tested at The Ohio State University for the treatment of Non-Hodgkin's lymphoma

Caption

HOSU-3 is a dihydroorotate dehydrogenase (DHODH) inhibitor currently being tested at The Ohio State University for the treatment of Non-Hodgkin's lymphoma.

Credit

The Ohio State University

Usage Restrictions

Usage only with credit and in story content related to HOSU-3, a dihydroorotate dehydrogenase (DHODH) inhibitor currently being tested at The Ohio State University for the treatment of Non-Hodgkin's lymphoma

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.